These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12043090)

  • 1. [More transparency facilities drug choice in general practice. Booster regimens in direct comparison].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():82. PubMed ID: 12043090
    [No Abstract]   [Full Text] [Related]  

  • 2. Saquinavir update.
    Treat Rev; 1997 Aug; (No 25):6. PubMed ID: 11364616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undetectable HIV levels after triple therapy with indinavir.
    AIDS Patient Care STDS; 1997 Jun; 11(3):193-4. PubMed ID: 11361795
    [No Abstract]   [Full Text] [Related]  

  • 4. Ritonavir and saquinavir combination: 12-week data at ICAAC.
    James JS
    AIDS Treat News; 1996 Oct; (No 256):3. PubMed ID: 11363880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A further option in PI therapy. Approval of a new protease inhibitor in the USA].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():30. PubMed ID: 16385868
    [No Abstract]   [Full Text] [Related]  

  • 6. Head-to-head study of protease inhibitors.
    AIDS Patient Care STDS; 1998 Jan; 12(1):63-4. PubMed ID: 11361890
    [No Abstract]   [Full Text] [Related]  

  • 7. Twice daily Indinavir trial stopped.
    TreatmentUpdate; 1998 Oct; 10(8):3-4. PubMed ID: 11365875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spring cleaning in trial land.
    Gilden D
    GMHC Treat Issues; 1997 Mar; 11(3):4-7. PubMed ID: 11364275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination study of Invirase and Norvir starting.
    AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633
    [No Abstract]   [Full Text] [Related]  

  • 10. Soft gel saquinavir has high exposure.
    AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crixivan reduces viral load.
    AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361665
    [No Abstract]   [Full Text] [Related]  

  • 12. [New formulation--fewer tablets--optimal effect].
    Krankenpfl J; 2005; 43(7-10):249. PubMed ID: 16515318
    [No Abstract]   [Full Text] [Related]  

  • 13. ACTG 320 trial halted as three-drug arm proves superior.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361796
    [No Abstract]   [Full Text] [Related]  

  • 14. Protease inhibitor update: treatment combination strategies.
    Mascolini M
    AIDS Treat News; 1996 Jan; (no 239):3. PubMed ID: 11363085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saquinavir switch study stopped.
    Treat Rev; 1997 Apr; (No 24):6. PubMed ID: 11364285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goodbye, Invirase. Hello, Fortovase.
    Vazquez E
    Posit Aware; 1998; 9(1):45-6. PubMed ID: 11365001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saquinavir/low-dose ritonavir: its use in HIV infection.
    Johnson M; Peters B
    AIDS Rev; 2003; 5(1):44-51. PubMed ID: 12875107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir.
    TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
    TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
    [No Abstract]   [Full Text] [Related]  

  • 20. Crixivan (Indinavir): three doses daily, not two, in most regimens.
    James JS
    AIDS Treat News; 1998 Oct; (No 304):4-5. PubMed ID: 11365863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.